STD Female Profile Test Cost and Details at Chughtai Lab

STD Female Profile at Chughtai Lab

The Sexually Transmitted Disease (STD) Female Profile at Chughtai Lab is a comprehensive, multi-parameter diagnostic panel designed to screen for and detect the most common sexually transmitted infections (STIs) in women. Sexually transmitted infections represent a significant global and regional public health challenge. In many cases, these infections remain entirely asymptomatic in females during their early stages. If left undiagnosed and untreated, chronic STIs can lead to severe, irreversible clinical complications, including Pelvic Inflammatory Disease (PID), fallopian tube scarring, ectopic pregnancy, chronic pelvic pain, and tubal factor infertility. Furthermore, active maternal STIs pose a critical risk of vertical transmission to the fetus during pregnancy or delivery, potentially causing congenital anomalies, neonatal infections, or premature birth.

Chughtai Lab, a premier diagnostic network in Pakistan, utilizes state-of-the-art laboratory technology to perform this comprehensive profile. The panel integrates advanced serological assays and molecular diagnostic techniques to identify viral, bacterial, and protozoal pathogens. By evaluating multiple parameters from a single clinical visit, the STD Female Profile offers a highly efficient, cost-effective, and clinically robust screening solution. This profile typically assesses key infectious markers, including Human Immunodeficiency Virus (HIV-1 and HIV-2), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Syphilis (Treponema pallidum), Chlamydia trachomatis, and Neisseria gonorrhoeae. The diagnostic value of this panel lies in its ability to detect infections early, enabling timely therapeutic intervention, preventing community transmission, and safeguarding female reproductive health.

Clinical Procedure: What to Expect

Patient Preparation

Appropriate patient preparation is essential to ensure the diagnostic accuracy and clinical validity of the STD Female Profile at Chughtai Lab. Patients are advised to adhere to the following guidelines prior to sample collection:

• Fasting Requirements: Strict fasting is generally not required for this profile, as the serological and molecular tests are not affected by dietary intake. However, patients should remain well-hydrated.
• Urine Sample Collection: If a first-catch urine sample is included in the profile for molecular testing (PCR), the patient must not urinate for at least one to two hours prior to sample collection. The first 10 to 20 mL of the urine stream (first-catch, not mid-stream) should be collected, as this portion contains the highest concentration of urethral pathogens.
• Vaginal or Cervical Swabs: If the profile requires a self-collected or clinician-collected vaginal or endocervical swab, patients should avoid douching, using vaginal medications, contraceptive creams, or personal lubricants for at least 24 to 48 hours before the test. It is also recommended to avoid sexual intercourse during this pre-test window.
• Medication History: Patients must inform the laboratory staff and their referring physician of any ongoing antimicrobial or antiviral therapies, as these medications can interfere with culture and molecular detection methods, potentially leading to false-negative results.

During the Procedure

The collection process at Chughtai Lab is conducted under strict aseptic conditions by highly trained phlebotomists and clinical staff, prioritizing patient comfort, privacy, and safety:

• Venipuncture (Blood Collection): A standard blood draw is performed to obtain serum or plasma. The phlebotomist identifies a suitable vein, typically in the antecubital fossa of the arm, cleanses the site with an antiseptic swab, and inserts a sterile, single-use needle. The blood is collected into appropriate vacuum tubes (usually gold-top serum separator tubes or purple-top EDTA tubes). Pressure is applied to the puncture site post-extraction, and a sterile adhesive bandage is applied.
• Urine Collection: The patient is provided with a sterile, leak-proof collection container and detailed instructions on how to collect a first-catch urine specimen safely within the laboratory’s private restroom facilities.
• Swab Collection (If Applicable): For endocervical or vaginal swab collection, the procedure is performed in a private, dedicated examination room. A sterile dacron or rayon swab is gently rotated against the vaginal wall or within the endocervical canal to collect epithelial cells and secretions.
• Safety and Comfort: The entire process takes approximately 10 to 15 minutes. All specimens are immediately labeled with unique barcoded identifiers matching the patient’s registration details to prevent pre-analytical errors.

When is an STD Female Profile Performed?

Routine Screening and Preventive Health

Routine screening is highly recommended for sexually active women, particularly those under the age of 25, as many STIs present with no discernible symptoms. Annual screening helps detect silent infections like Chlamydia and Gonorrhea, which can quietly damage the reproductive tract if left untreated. Regular screening is a cornerstone of proactive preventive gynecology.

Presence of Genitourinary Symptoms

Physicians frequently order the STD Female Profile when a patient presents with clinical symptoms suggestive of a lower reproductive tract infection. These symptoms include abnormal vaginal discharge (altered color, consistency, or odor), dysuria (painful urination), pelvic pain, dyspareunia (painful intercourse), post-coital bleeding, or unexplained genital pruritus, lesions, and ulcers.

High-Risk Exposure or New Sexual Partner

The profile is clinically indicated following a known or suspected exposure to a partner with a confirmed sexually transmitted infection. It is also highly recommended when entering a new sexual relationship, or for individuals with multiple concurrent sexual partners, to establish baseline health status and prevent mutual transmission.

Prenatal and Pre-pregnancy Evaluation

Screening is a critical component of preconception care and early prenatal workups. Undetected STIs can have devastating consequences on pregnancy outcomes, including spontaneous abortion, stillbirth, low birth weight, and ophthalmia neonatorum. Identifying and treating these infections early in pregnancy protects both maternal and neonatal health.

Pre-marital Diagnostic Screening

In many clinical practices across Pakistan, pre-marital health screening is increasingly utilized to foster transparency and mutual health awareness between partners. The STD Female Profile provides comprehensive diagnostic reassurance, ensuring that any pre-existing, asymptomatic infections are managed appropriately before marriage.

What Does an STD Female Profile Detect?

The STD Female Profile at Chughtai Lab is designed to detect a broad spectrum of viral, bacterial, and protozoal pathogens through targeted laboratory assays:

• Human Immunodeficiency Virus (HIV-1 and HIV-2): Detects HIV-1/2 antibodies and the p24 antigen, allowing for early detection of HIV infection during the acute phase.
• Hepatitis B Surface Antigen (HBsAg): Screens for active or chronic Hepatitis B viral infection, which can be transmitted sexually or vertically.
• Hepatitis C Virus (HCV) Antibodies: Identifies exposure to the Hepatitis C virus, a major cause of chronic liver disease and cirrhosis.
• Syphilis (Treponema pallidum): Utilizes serological tests (such as VDRL/RPR or Treponema-specific antibody assays) to detect active, latent, or past syphilis infections.
• Chlamydia trachomatis: Employs highly sensitive molecular PCR or antigen detection to identify this common bacterial pathogen responsible for urethritis, cervicitis, and pelvic inflammatory disease.
• Neisseria gonorrhoeae: Detects the causative bacterium of gonorrhea, which can lead to severe pelvic infections and disseminated gonococcal disease if untreated.
• Trichomonas vaginalis (Optional/Panel Dependent): Identifies the flagellated protozoan parasite responsible for trichomoniasis, a common cause of vaginitis and discharge.
• Herpes Simplex Virus (HSV-1 and HSV-2) Antibodies (Optional/Panel Dependent): Measures type-specific IgG and IgM antibodies to determine past exposure or active/recurrent genital herpes infections.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is widely recognized for its highly efficient laboratory workflow and rapid turnaround times. Most serological components of the STD Female Profile (such as HIV, HBsAg, Anti-HCV, and Syphilis screening) are typically completed within 24 hours of sample collection. Molecular diagnostic components, such as Chlamydia and Gonorrhea PCR assays, may require 24 to 48 hours due to the complex nature of nucleic acid amplification technology.

Patients can access their diagnostic reports securely through multiple convenient digital channels. Once the results are verified by a consultant pathologist, an automated SMS notification is sent to the patient’s registered mobile number. Reports can be downloaded directly from the official Chughtai Lab website portal or via the dedicated Chughtai Healthcare mobile application. Hard copies of the reports can also be collected from any Chughtai Lab collection center nationwide or delivered directly to the patient’s home through their home delivery service.

STD Female Profile Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
HIV-1 & HIV-2 Antibodies / p24 Antigen	Non-Reactive	Reactive (indicates potential HIV infection; requires confirmatory Western Blot or PCR testing)
Hepatitis B Surface Antigen (HBsAg)	Non-Reactive	Reactive (indicates active acute or chronic Hepatitis B infection)
Hepatitis C Antibody (Anti-HCV)	Non-Reactive	Reactive (indicates exposure to HCV; requires HCV RNA PCR for confirmation of active replication)
Syphilis Screening (VDRL / RPR / Treponemal Ab)	Non-Reactive / Negative	Reactive / Positive (indicates active, latent, or treated syphilis infection; requires clinical correlation)
Chlamydia trachomatis DNA (PCR)	Not Detected	Detected (indicates active Chlamydia infection of the genitourinary tract)
Neisseria gonorrhoeae DNA (PCR)	Not Detected	Detected (indicates active Gonorrhea infection of the genitourinary tract)
Trichomonas vaginalis (PCR / Microscopy)	Not Detected / Negative	Detected / Positive (indicates active trichomoniasis vaginal infection)
Herpes Simplex Virus Type 2 (HSV-2) IgG	Negative	Positive (indicates past exposure or latent genital herpes infection)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for STD Female Profile?

• Experienced Healthcare Professionals: Chughtai Lab is staffed by highly qualified consultant pathologists, microbiologists, and medical technologists who oversee all testing procedures.
• Patient-Focused Care: The laboratory ensures a highly compassionate, non-judgmental, and supportive environment for patients undergoing sensitive diagnostic screenings.
• Strict Confidentiality: Chughtai Lab maintains the highest standards of patient privacy and data security, ensuring that all STD profile results are kept strictly confidential.
• Advanced Diagnostic Technology: Utilizing state-of-the-art automated analyzers and molecular PCR platforms to deliver highly accurate and reproducible results.
• ISO 15189 Certified Laboratories: Many of Chughtai Lab’s core facilities hold international quality management certifications, reflecting their commitment to diagnostic excellence.
• Convenient Home Sample Collection: Patients can schedule a professional phlebotomist to collect blood and urine samples in the privacy of their own homes.
• Extensive Nationwide Network: With hundreds of collection centers across Pakistan, accessing high-quality diagnostic services is convenient and accessible.
• Seamless Digital Report Access: Secure online portals and mobile applications allow patients to view, download, and share their diagnostic reports effortlessly.